Synthpop, a Cambridge, MA-based healthcare AI company building agentic automation, has raised $15 million in a Series A funding round.
Investors
The round was led by Ansa Capital, with participation from Defy.vc, Peterson Ventures, Storm Ventures, and strategic investor Bruce Broussard.
Ansa Capital is a venture capital firm focused on creating a new model for founders: equal, aligned, and relentless. It partners with founders of growth‑stage tech companies to support their scaling and strategic development. Ansa combines capital investment with guidance through its network of operators and advisors to help portfolio companies grow. Based in New York, the firm invests in growth-stage technology companies.
Synthpop Use of Funds
The funding will expand Synthpop’s AI workflow capabilities, deepen integrations with EHR and other healthcare systems, grow the team, and scale into additional healthcare verticals.
About Synthpop
Synthpop is a healthcare AI company building agentic automation to reduce administrative bottlenecks in payer, provider, and patient operations. Its platform unifies document intelligence, payer-aware reasoning, and conversational voice agents to automate healthcare business processes, including referrals, prior authorizations, eligibility checks, claims follow-ups, and patient access. Synthpop integrates directly with EHR, billing, and e-prescribing systems. Based in Cambridge, Massachusetts, the platform serves a wide range of healthcare organizations across diagnostics, fertility, DME, and more.
Funding Details
Company: Synthpop Inc.
Raised: $15.0M
Round: Series A
Funding Date: February 2026
Lead Investor: Ansa Capital
Additional Investors: Defy.vc, Peterson Ventures, Storm Ventures, Bruce Broussard
Company Website: https://www.synthpop.ai/
Software Category: Healthcare AI / Automation Platform
Source: https://www.businesswire.com/news/home/20260204938691/en/